Skip to main content

Table 3 Comparison of classifier scores in patients who reached an endpoint compared to those who did not

From: Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Endpoint

Yes

No

p value

30% decline eGFR (29 events)

0.239 ± 0.414

0.228 ± 0.390

0.886

Transition micro to macroalbuminuria (19 events)

0.354 ± 0.238

0.145 ± 0.406

*0.036

Cardiovascular event (31 events)

0.331 ± 0.389

0.216 ± 0.405

0.156

Mortality (20 events)

0.438 ± 0.355

0.208 ± 0.403

*0.017

  1. We defined the following endpoints for analysis: (1) All-cause mortality. (2) CV events. (3) 30% decline in eGFR. (4) Transition from micro to macroalbuminuria. With regard to the latter, there were 19 patients who progressed and 73 who remained microalbuminuric or regressed; we did not analyse data on people who were macroalbuminuric at baseline. Data are mean ± SD, p value of < 0.05 deemed statistically significant. Comparisons are by 2 sample t test. p < 0.05 and * denote statistical significance